Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice

Journal of Steroid Biochemistry and Molecular Biology

Volumn 170, Issue , 2017, Pages 39-48

  Van Sinderen, Michelle ^a,c   Steinberg, Gregory ^b,d   Jorgensen, Sebastian B ^b,e   Honeyman, Jane ^b   Chow, Jenny D Y ^c   Simpson, Evan R ^a   Jones, Margaret E E ^f   Boon, Wah Chin ^b,c  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MCMASTER UNIVERSITY   (Canada)

^e NOVO NORDISK A S   (Denmark)

^f EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Aromatase knockout; Estrogens; Glucose homeostasis; Glucose tolerance test; Insulin resistance; Insulin tolerance test; Pyruvate tolerance test

Indexed keywords

ESTRADIOL; ESTROGEN; GLUCOSE; INSULIN; PYRUVIC ACID; AROMATASE;

ADIPOSE TISSUE; AGING; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MALE; MOUSE; NONHUMAN; PHENOTYPE; SEX DIFFERENCE; ANIMAL; BODY MASS; C57BL MOUSE; DEFICIENCY; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; SEXUAL CHARACTERISTICS;

ANIMALS; AROMATASE; BODY MASS INDEX; ESTROGENS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; SEX CHARACTERISTICS;

EID: 84977638935     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.05.013     Document Type: Article

References (38)

1. Elbers, J.M., Giltay, E.J., Teerlink, T., Scheffer, P.G., Asscheman, H., Seidell, J.C., Gooren, L.J., Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin. Endocrinol. (Oxf.) 58:5 (2003), 562–571.
2. Godsland, I.F., Oestrogens and insulin secretion. Diabetologia 48:11 (2005), 2213–2220.
3. Guercio, G., Di Palma, M.I., Pepe, C., Saraco, N.I., Prieto, M., Saure, C., Mazza, C., Rivarola, M.A., Belgorosky, A., Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency. Horm. Res. 72:6 (2009), 370–376.
4. Faria, A.N., Ribeiro Filho, F.F., Gouveia Ferreira, S.R., Zanella, M.T., Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes. Res. 10:12 (2002), 1203–1206.
5. Dechering, K., Boersma, C., Mosselman, S., Estrogen receptors alpha and beta: two receptors of a kind?. Curr. Med. Chem. 7:5 (2000), 561–576.
6. Deroo, B.J., Korach, K.S., Estrogen receptors and human disease. J. Clin. Invest. 116:3 (2006), 561–570.
7. Nilsson, M., Dahlman, I., Ryden, M., Nordstrom, E.A., Gustafsson, J.A., Arner, P., Dahlman-Wright, K., Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females. Int. J. Obes. (Lond). 31:6 (2007), 900–907.
8. Ribas, V., Nguyen, M.T., Henstridge, D.C., Nguyen, A.K., Beaven, S.W., Watt, M.J., Hevener, A.L., Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER{alpha} deficient mice. Am. J. Physiol. Endocrinol. Metab., 2016, 2009.
9. Foryst-Ludwig, A., Clemenz, M., Hohmann, S., Hartge, M., Sprang, C., Frost, N., Krikov, M., Bhanot, S., Barros, R., Morani, A., Gustafsson, J.A., Unger, T., Kintscher, U., Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet., 4(6), 2008, e1000108.
10. Galic, S., Oakhill, J.S., Steinberg, G.R., Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol., 2009.
11. Nuttall, F.Q., Ngo, A., Gannon, M.C., Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant?. Diabetes Metab. Res. Rev. 24:6 (2008), 438–458.
12. Lonardo, A., Lombardini, S., Ricchi, M., Scaglioni, F., Loria, P., Review article: hepatic steatosis and insulin resistance. Aliment. Pharmacol. Ther. 22:Suppl 2 (2005), 64–70.
13. Denzer, C., Thiere, D., Muche, R., Koenig, W., Mayer, H., Kratzer, W., Wabitsch, M., Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J. Clin. Endocrinol. Metab. 94:10 (2009), 3872–3881.
14. Hewitt, K.N., Pratis, K., Jones, M.E., Simpson, E.R., Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145:4 (2004), 1842–1848.
15. Jones, M.E., Thorburn, A.W., Britt, K.L., Hewitt, K.N., Misso, M.L., Wreford, N.G., Proietto, J., Oz, O.K., Leury, B.J., Robertson, K.M., Yao, S., Simpson, E.R., Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid Biochem. Mol. Biol. 79:1–5 (2001), 3–9.
16. Van Sinderen, M.L., Steinberg, G.R., Jorgensen, S.B., To, S.Q., Knower, K.C., Clyne, C.D., Honeyman, J., Chow, J.D., Herridge, K.A., Jones, M.E., Simpson, E.R., Boon, W.C., Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse. PLoS One, 9(2), 2014, e87230.
17. Van Sinderen, M.L., Steinberg, G.R., Jorgensen, S.B., Honeyman, J., Chow, J.D., Herridge, K.A., Winship, A.L., Dimitriadis, E., Jones, M.E., Simpson, E.R., Boon, W.C., Effects of estrogens on adipokines and glucose homeostasis in female aromatase knockout mice. PLoS One, 10(8), 2015, e0136143.
18. Geer, E.B., Shen, W., Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 6:Suppl 1 (2009), 60–75.
19. Combs, T.P., Berg, A.H., Rajala, M.W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J.C., Patti, M.E., Klein, S.L., Weinstein, R.S., Scherer, P.E., Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52:2 (2003), 268–276.
20. Clark, J.B., Palmer, C.J., Shaw, W.N., The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol. Med. 173:1 (1983), 68–75.
21. Takeda, K., Toda, K., Saibara, T., Nakagawa, M., Saika, K., Onishi, T., Sugiura, T., Shizuta, Y., Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 176:2 (2003), 237–246.
22. Gonzalez, C., Alonso, A., Grueso, N.A., Diaz, F., Esteban, M.M., Fernandez, S., Patterson, A.M., Role of 17beta-estradiol administration on insulin sensitivity in the rat: implications for the insulin receptor. Steroids 67:13–14 (2002), 993–1005.
23. Muraki, K., Okuya, S., Tanizawa, Y., Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr. J. 53:6 (2006), 841–851.
24. Naaz, A., Zakroczymski, M., Heine, P., Taylor, J., Saunders, P., Lubahn, D., Cooke, P.S., Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 34:11–12 (2002), 758–763.
25. Kleiblova, P., Dostalova, I., Bartlova, M., Lacinova, Z., Ticha, I., Krejci, V., Springer, D., Kleibl, Z., Haluzik, M., Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol. Cell. Endocrinol. 314:1 (2010), 150–156.
26. Nemoto, Y., Toda, K., Ono, M., Fujikawa-Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T., Shizuta, Y., Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J. Clin. Invest. 105:12 (2000), 1819–1825.
27. Harrison, S.A., Neuschwander-Tetri, B.A., Pharmacologic management of nonalcoholic fatty liver disease. Clin. Liver Dis. 8:3 (2004), 715–728 (xii).
28. Loria, P., Lonardo, A., Carulli, N., Should nonalcoholic fatty liver disease be renamed?. Dig. Dis. 23:1 (2005), 72–82.
29. Samuel, V.T., Liu, Z.X., Qu, X., Elder, B.D., Bilz, S., Befroy, D., Romanelli, A.J., Shulman, G.I., Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279:31 (2004), 32345–32353.
30. Lonardo, A., Carani, C., Carulli, N., Loria, P., ‘Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J. Hepatol. 44:6 (2006), 1196–1207.
31. Heine, P.A., Taylor, J.A., Iwamoto, G.A., Lubahn, D.B., Cooke, P.S., Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97:23 (2000), 12729–12734.
32. Bryzgalova, G., Gao, H., Ahren, B., Zierath, J.R., Galuska, D., Steiler, T.L., Dahlman-Wright, K., Nilsson, S., Gustafsson, J.A., Efendic, S., Khan, A., Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:3 (2006), 588–597.
33. Gao, H., Bryzgalova, G., Hedman, E., Khan, A., Efendic, S., Gustafsson, J.A., Dahlman-Wright, K., Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol. Endocrinol. 20:6 (2006), 1287–1299.
34. Obici, S., Zhang, B.B., Karkanias, G., Rossetti, L., Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8:12 (2002), 1376–1382.
35. Muse, E.D., Lam, T.K., Scherer, P.E., Rossetti, L., Hypothalamic resistin induces hepatic insulin resistance. J. Clin. Invest. 117:6 (2007), 1670–1678.
36. Hill, R.A., Pompolo, S., Jones, M.E., Simpson, E.R., Boon, W.C., Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice. Mol. Cell. Neurosci. 27:4 (2004), 466–476.
37. Musatov, S., Chen, W., Pfaff, D.W., Mobbs, C.V., Yang, X.J., Clegg, D.J., Kaplitt, M.G., Ogawa, S., Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 104:7 (2007), 2501–2506.
38. Le May, C., Chu, K., Hu, M., Ortega, C.S., Simpson, E.R., Korach, K.S., Tsai, M.J., Mauvais-Jarvis, F., Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. U. S. A. 103:24 (2006), 9232–9237.